Mr. Todd Krueger has been a business advisor for Neofluidics since July 2015 and board member since 2016. Mr. Krueger has 20 years of experience in healthcare strategy, business development, operations and finance. He led commercial efforts for the genomics platform at the Broad Institute. Previously, Mr. Krueger held senior positions at Claritas Genomics and Life Technologies. He has also been involved in the founding of several biotech startups, including Gynesonics, Nodality and Anestis Therapeutics. Mr. Krueger co-founded Fluidigm Corporation in May 1999 and served as its Chief Financial Officer and Vice President of Corporate Development. Before joining Fluidigm, he provided strategic advice during their initial formation. Prior to that, Mr. Krueger served as a Management Consultant at Bain & Company, Inc. and McKinsey & Company, Inc. He holds a B.A. in Economics from Northwestern University and an M.B.A. from Northwestern's Kellogg Graduate School of Management.